Skip to Content


In the US, Cilostazol (cilostazol systemic) is a member of the following drug classes: miscellaneous cardiovascular agents, platelet aggregation inhibitors and is used to treat Intermittent Claudication.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories


Antiplatelet agent: Phosphodiesterase inhibitor

Chemical Names

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril (WHO)

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrochinolin-2-on (IUPAC)

Foreign Names

  • Cilostazolum (Latin)
  • Cilostazol (German)
  • Cilostazol (French)
  • Cilostazol (Spanish)

Generic Names

  • Cilostazol (OS: JAN, USAN, BAN)
  • OPC 13013 (IS: Otsuka)
  • OPC 21 (IS: Otsuka)
  • Cilostazol (PH: JP XVI, USP 38)

Brand Names


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Prop.INNProposed International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.